Systemic Treatment of Atopic Eczema & Prigo Nodularis: Latest Insights

by Dr Natalie Singh - Health Editor
0 comments

Real-World Data for Effective eczema Management

Real-World Registers transform raw data into directly applicable insights for clinical practice.

In this 5th edition of our webcast, we share the most recent data and practical experiences regarding the treatment of atopic eczema, Prurigo nodularis, Hand eczema, and atopic comorbidities in both adults and children.

The following topics are discussed:

* Adults with Atopic Eczema & Prurigo Nodularis: The latest real-world data on biologics and JAK inhibitors, how to recognise and manage common side effects in daily practice, when and how to switch between treatments, current insights regarding pregnancy, long-term experiences with Prurigo nodularis, and how personalized therapy and dosing for Atopic Dermatitis and Prurigo nodularis can be implemented in practice. We also demonstrate how to practically apply the choice matrix from the directive.
* Children with Severe Atopic Eczema: An overview of long-term data and drug survival, with attention to vaccinations and tapering. We discuss how the atopic march and possible disease modification through the use of biologics and JAK inhibitors translate into clinical practice. The choice matrix for pediatric Atopic Dermatitis is also discussed.
* Hand Eczema: The most recent Real-World data for systemic treatment of hand eczema, including considerations for children. we explore the choices available for both atopic and non-atopic hand eczema.

This is an excellent opportunity to ask questions, gain practical knowledge, and take directly applicable insights into your clinical practice. Don’t miss it!

Speakers

Prof.Dr. Marjolein de Bruin – Weller

Dermatologist
UMC Utrecht

Dr.Lisette van der Wal

Dermatologist
Admiraal Karel Doorman Ziekenhuis

Related Posts

Leave a Comment